Jan 12, 2021 / 07:00PM GMT
James Daniel Gordon - JPMorgan Chase & Co, Research Division - Senior Analyst
Good afternoon and good evening. I'm James Gordon, JPMorgan European Healthcare Analyst. And today at the JPMorgan Healthcare conference, it's my pleasure to introduce the Alcon session with Alcon's CEO, David Endicott.
Today, we're going to have a 20-minute presentation from David, and then we're going to have 20 minutes for questions, and then we'll also be joined by 2 other members of the Alcon executive team: CFO, Tim Stonesifer; and President and Global Business & Innovation, Michael Onuscheck (Operator Instructions)
And with that said, I'd like to welcome David to the conference. David, over to you.
David J. Endicott - Alcon Inc. - CEO & Director
Thanks, James. Appreciate it. Welcome, everybody. I'm pleased to be here to give you a little bit of background on Alcon. We're going to be referring to a presentation that's available online.
Just starting off, Slide 3 on this. Just for those of you who may not be familiar with our story and who
Alcon AG at JPMorgan Healthcare Conference (Virtual) Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot